Wells Fargo & Company Ginkgo Bioworks Holdings, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 81,946 shares of DNA stock, worth $30,320. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,946
Previous 75,423
8.65%
Holding current value
$30,320
Previous $127,000
25.2%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DNA
# of Institutions
361Shares Held
942MCall Options Held
845KPut Options Held
2.54M-
Viking Global Investors LP143MShares$52.9 Million0.63% of portfolio
-
Baillie Gifford & CO134MShares$49.7 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA126MShares$46.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY72.9MShares$27 Million0.0% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$25.8 Million21.46% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $476M
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...